KemPharm changes name to Zevra Therapeutics; ticker to become ZVRA on March 1, 2023

ZEVRA THERAPEUTICS, INC.

Name change effective February 21, 2023 via Delaware certificate of amendment.
Common stock ticker to change from KMPH to ZVRA on Nasdaq on or about March 1, 2023.
No shareholder vote required; rights of shareholders, creditors, and CUSIP unchanged.
Bylaws amended and restated to reflect new name; no other charter or bylaw changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ZEVRA THERAPEUTICS, INC.: Amended and restated bylaws to reflect name change to Zevra Therapeutics, Inc (effective 2023-02-21).

Change: bylaw amendment
Effective: 2023-02-21

Exact text from the filing

The Company also amended and restated its amended and restated bylaws (the “Amended and Restated Bylaws”) effective on February 21, 2023, to reflect the Name Change.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ZEVRA THERAPEUTICS, INC.: Changed corporate name to Zevra Therapeutics, Inc. via certificate of amendment to certificate of incorporation (effective 2023-02-21).

Change: charter amendment
Effective: 2023-02-21

Exact text from the filing

Effective February 21, 2023, KemPharm, Inc. (the “Company”) changed its corporate name to Zevra Therapeutics, Inc. (the “Name Change”) pursuant to a certificate of amendment to the Company’s certificate of incorporation (the “Charter Amendment”)

View on SEC.gov

Browse all governance changes →

ZEVRA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-004450

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.